))
ActiPulse Neuroscience
Manage episode 313759404 series 3285120
Content provided by Alex Rochegude. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Alex Rochegude or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode, Alex Rochegude, Cofounder of Predictiv, invited Adrien Chatillon to discuss about a new generation of medical treatments for Brain Diseases.
Adrien is a serial entrepreneur, and the CEO and cofounder of Actipulse Neuroscience, a medical company specialized in Non-Invasive Brain Stimulation therapeutics for the treatment of Major Depressive Disorder, and that is also under clinical trials for Alzheimer's Disease and post-stroke rehabilitation. Actipulse Neuroscience has already treated more than 11,000 patients in the past two years for Major Depressive Disorders, and has an objective of reaching 100,000 patients by 2025.
--- Send in a voice message: https://podcasters.spotify.com/pod/show/thefutureofhealth/message6 episodes
Share
